Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : A US National Health Care System? -- Ignore unavailable to you. Want to Upgrade?

To: Robohogs who wrote (1841)	8/13/2007 10:29:33 AM
From: TimF	Read Replies (1) \| Respond to of 42652

Thanks for the information. Drugs where only one of the issues I posted about. If the total difference from drug costs is 2-3%, then the difference from non-generic drugs would be more than that (because the difference in generics works in the other direction). What exactly do you mean by 2 to 3% higher US prices? Are you saying that 2 to 3 % of the difference is from prescription drugs, or 2 to 3 percentage points. If the difference in costs is 50% 2 percentage points is a 4% difference, if your counting the difference in total health care costs. If instead your saying that its two to three percent of GDP difference than that's a huge difference (but I doubt that's what you mean, that seems to high, and also if that was the case you wouldn't use it to argue that the drug price difference is only a relatively minor part of the difference in costs for health care). Also do you have any source to data about the total and per capita differences in prescription drug data?